Human respiratory syncytial virus (HRSV) is a major cause of lower respiratory tract infections (LRTIs) among infants and young children worldwide and is also a major cause of morbidity in children under 1 year of age (2). Bronchiolitis and pneumonia, which are attributed to HRSV infection, are observed most frequently during the first few months of life (7). Almost all children are infected with HRSV by 2 years of age, and half of all children experience two infections (8, 13).Based on genetic and antigenic variations in structural proteins, HRSV isolates have been subdivided into two major antigenic groups (i.e., A and B), and both subgroups are associated with different severities of infection (15,18,(22)(23)(24). The nucleotide and deduced amino acid sequence similarities are 67% and 53% between group A and group B strains, respectively (11, 19). Antigenic variability is thought to contribute to the capacity of the virus to infect people repeatedly and cause yearly outbreaks. These characteristics may pose a challenge for vaccine design and development (27). The G protein, a surface-expressed glycoprotein that is associated with attachment of the virus, shows the largest antigenic and genetic differences between the two antigenic HRSV subgroups and is one of the targets for neutralization and protective antibody responses (1, 19). The G protein contains two hypervariable regions; the second variable region, which corresponds to the C-terminal region of the G protein (HVR2), reflects overall G protein gene variability and has been analyzed in molecular epidemiological studies (9,(25)(26)(27)(28).Although HRSV has been recognized as an important agent, no effective vaccine is currently available for prophylaxis and there is no effective antiviral treatment against current HRSV infections. The importance of strain differences in relation to clinical features and vaccine development has not been fully elucidated (8,22). In the present study, 894 children with acute respiratory tract infections (ARTIs) were examined over three consecutive seasons for the presence of HRSV, and HRSV strains were genotyped by sequencing HVR2. Demographic and clinical information was collected from all patients. The prevalence and clinical and molecular characterization of HRSV genotypes were further analyzed. MATERIALS AND METHODSPatients and specimens. From December 2006 to March 2009, 894 nasopharyngeal aspirates (NPAs) were collected from children with ARTIs on Tuesday every week in the First Hospital of Lanzhou University, China. ARTIs were classified according to WHO definitions (38). Informed consent was obtained from the parents of all children who provided specimens. The study protocol was approved by the hospital ethics committee. All NPA specimens were collected and transported immediately to the laboratory at the National Institute for Viral

High coercivity L1 0 -ordered (FePt) 1−x Ag x nanoparticles (NPs) were directly synthesized using a one-step solution method without post-thermal annealing. The effect of silver additive on the morphology, chemical ordering, and magnetic properties of FePt NPs was studied. Magnetic measurements showed that the FePt NPs without Ag additive were soft magnetic with a coercivity of 300 Oe, whereas a record coercivity of 7600 Oe was obtained when the molar ratio of Ag reached 29% in FePtAg. High-resolution transmission electron microscopy and X-ray diffraction analyses proved that Ag atoms in the L1 0 -phase FePtAg NPs were segregated on the surface of the particles, which revealed that the diffusion of Ag atoms out of the FePt grains is the major driving force behind the L1 0 structure formation.

No abstract

No abstract

Background: Hypoxia is crucial in the initiation and progression of tumor metastasis. Circular RNAs (CircRNAs) comprise a novel group of non-coding, RNase R resistant and regulatory RNAs which are generated by 'back-splicing' processes. However, the characterization and function of circRNAs in hypoxic cancer cells remain unknown.Methods: High throughput RNA-seq assay was performed in lung adenocarcinoma cells (A549) under either normoxic or hypoxic conditions. Bioinformatic analysis of differentially expressed circRNAs was conducted and their target genes were predicted and partially confirmed.Results: Hypoxia increased the expression of hypoxia-inducible factor 1 alpha (HIF-1α) and its downstream genes in A549 cells and enhanced cell migration ability. Comprehensive analysis of global circRNAs expression profiles of A549 identified a total of 558 circRNAs candidates, among which 65 circRNAs were differentially expressed (35 upregulated and 30 downregulated) in hypoxic cancer cells. The difference in their circRNA expressions were compared by computational analysis and circRNA-miRNA networks were constructed. We further characterized one circRNA (hsa_circ_0008193) derived from the FAM120A gene and renamed it as circFAM120A. The expression of circFAM120A, as validated by reverse transcription polymerase chain reaction, was significantly downregulated in both hypoxic A549 and lung cancer tissue from patients with lymph node metastasis. Gene ontology (GO) enrichment analysis and KEGG pathway analysis revealed that circFAM120A may participate in lung cancer development.Conclusions: CircRNAs profiles were altered in lung adenocarcinoma under hypoxia and circFAM120A may have the potential to be a new biomarker of lung adenocarcinoma hypoxia.

No abstract

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

No abstract